241 related articles for article (PubMed ID: 12500202)
1. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
Graupera M; García-Pagán JC; Abraldes JG; Peralta C; Bragulat M; Corominola H; Bosch J; Rodés J
Hepatology; 2003 Jan; 37(1):172-81. PubMed ID: 12500202
[TBL] [Abstract][Full Text] [Related]
2. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
Graupera M; March S; Engel P; Rodés J; Bosch J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G763-70. PubMed ID: 15550559
[TBL] [Abstract][Full Text] [Related]
3. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas.
Loureiro-Silva MR; Cadelina GW; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G567-74. PubMed ID: 12490431
[TBL] [Abstract][Full Text] [Related]
4. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.
Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; García-Calderó H; Bosch J; García-Pagán JC
J Hepatol; 2007 Aug; 47(2):220-7. PubMed ID: 17459512
[TBL] [Abstract][Full Text] [Related]
5. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers.
Graupera M; García-Pagán JC; Parés M; Abraldes JG; Roselló J; Bosch J; Rodés J
J Hepatol; 2003 Oct; 39(4):515-21. PubMed ID: 12971960
[TBL] [Abstract][Full Text] [Related]
7. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
Yang YY; Huang YT; Tsai TH; Hou MC; Lee FY; Lee SD; Lin HC
Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967
[TBL] [Abstract][Full Text] [Related]
8. Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.
Rodríguez-Vilarrupla A; Graupera M; Matei V; Bataller R; Abraldes JG; Bosch J; García-Pagán JC
Liver Int; 2008 Apr; 28(4):566-73. PubMed ID: 18339082
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.
Gupta TK; Toruner M; Chung MK; Groszmann RJ
Hepatology; 1998 Oct; 28(4):926-31. PubMed ID: 9755227
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
[TBL] [Abstract][Full Text] [Related]
11. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC
Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
[TBL] [Abstract][Full Text] [Related]
13. Roles of anandamide in the hepatic microcirculation in cirrhotic rats.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G328-34. PubMed ID: 16407591
[TBL] [Abstract][Full Text] [Related]
14. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
15. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).
Steib CJ; Gerbes AL; Bystron M; Op den Winkel M; Härtl J; Roggel F; Prüfer T; Göke B; Bilzer M
J Hepatol; 2007 Aug; 47(2):228-38. PubMed ID: 17573142
[TBL] [Abstract][Full Text] [Related]
16. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR
Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810
[TBL] [Abstract][Full Text] [Related]
17. Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers.
Loureiro-Silva MR; Iwakiri Y; Abraldes JG; Haq O; Groszmann RJ
J Hepatol; 2006 May; 44(5):886-93. PubMed ID: 16545481
[TBL] [Abstract][Full Text] [Related]
18. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
19. Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: role of cyclooxygenase.
Sato K; Li J; Metais C; Bianchi C; Sellke F
J Surg Res; 2000 May; 90(2):138-43. PubMed ID: 10792954
[TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2 in early BDL-induced portal hypertension.
Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
